Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

E7070 in Treating Patients With Stage IV Melanoma

NCT00014625

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Kaiser Franz Josef Hospital Vienna, Austria
  • Institut Jules Bordet Brussels, Belgium
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Leon Berard Lyon, France
View Trial Details
Completed

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

NCT00003989

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Universitaetsklinik Innsbruck, Austria
  • Kaiser Franz Josef Hospital Vienna (Wien), Austria
  • Institut Jules Bordet Brussels (Bruxelles), Belgium
  • Ludwig Institute for Cancer Research-Brussels Branch Brussels (Bruxelles), Belgium
View all 27 locations
View Trial Details
Completed

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

NCT00257205

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Mobile, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 143 locations
View Trial Details
Completed

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00002669

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Landeskrankenanstalten - Salzburg Salzburg, Austria
  • Hopital Universitaire Erasme Brussels, Belgium
  • Institut Jules Bordet Brussels (Bruxelles), Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
View all 24 locations
View Trial Details
Completed

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

NCT00094107

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Pfizer Investigational Site Orange, California, United States
  • Pfizer Investigational Site Miami Beach, Florida, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
View Trial Details

Related conditions